• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌:高甲状腺肿流行地区的甲状腺外侵犯、淋巴结转移和复发的危险因素。

Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

机构信息

Division of Endocrine Surgery, Department of Surgery, Istituto di Semeiotica Chirurgica, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, L. go A. Gemelli 8, 00168, Rome, Italy.

出版信息

World J Surg. 2010 Jun;34(6):1214-21. doi: 10.1007/s00268-009-0375-x.

DOI:10.1007/s00268-009-0375-x
PMID:20052467
Abstract

BACKGROUND

Although papillary thyroid microcarcinoma (PTMC) is diagnosed with increasing frequency, the best therapeutic option and follow-up protocol have not been established yet, especially in the case of incidental diagnosis. We reviewed our series of patients with PTMC to determine risk factors for recurrence in an area where there is a high prevalence of goiter.

METHODS

The medical records of all patients who underwent thyroidectomy with a final pathology report of PTMC between October 2002 and June 2007 were reviewed. PTMC was defined as a papillary thyroid carcinoma 10 mm or less in diameter. Follow-up evaluation was obtained by outpatient consultation and/or telephone interview.

RESULTS

In a series of 2,220 patients who underwent thyroidectomy for a thyroid carcinoma, 933 had a PTMC. Diagnosis was incidental in 704 patients (75.5%). Upon multivariate analysis, tumor size, nonincidental diagnosis, and neck node metastases at diagnosis were independent risk factors for extracapsular spread (ECS), while ECS, multifocal disease, and number of removed lymph nodes were independent risk factors for lymph node metastases at diagnosis. Follow-up evaluation was completed in 287 patients, 9 (3.1%) of whom experienced recurrence. The number of removed and metastasized nodes at first operation and the length of the follow-up were independent risk factors for recurrent disease.

CONCLUSIONS

Incidental diagnosis of PTMC is frequent in a high prevalence of goiter area. PTMC shows a variable degree of aggressiveness. Management protocols should be based on patient- and tumor-related prognostic factors, as for larger tumors.

摘要

背景

尽管甲状腺微小乳头状癌(PTMC)的诊断率越来越高,但尚未确定最佳的治疗选择和随访方案,尤其是在偶然诊断的情况下。我们回顾了我们的一系列 PTMC 患者病例,以确定在甲状腺肿高发地区复发的危险因素。

方法

回顾了 2002 年 10 月至 2007 年 6 月期间所有接受甲状腺切除术且最终病理报告为 PTMC 的患者的病历。PTMC 定义为直径 10 毫米或以下的甲状腺乳头状癌。通过门诊咨询和/或电话访谈获得随访评估。

结果

在 2220 例接受甲状腺癌切除术的患者中,有 933 例患有 PTMC。704 例(75.5%)为偶然诊断。多因素分析显示,肿瘤大小、非偶然诊断和诊断时颈部淋巴结转移是包膜外扩散(ECS)的独立危险因素,而 ECS、多灶性疾病和切除的淋巴结数量是诊断时淋巴结转移的独立危险因素。对 287 例患者进行了随访评估,其中 9 例(3.1%)复发。首次手术切除和转移的淋巴结数量以及随访时间的长短是疾病复发的独立危险因素。

结论

在甲状腺肿高发地区,PTMC 的偶然诊断较为常见。PTMC 具有不同程度的侵袭性。管理方案应基于患者和肿瘤相关的预后因素,与较大肿瘤的管理方案相同。

相似文献

1
Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.甲状腺微小乳头状癌:高甲状腺肿流行地区的甲状腺外侵犯、淋巴结转移和复发的危险因素。
World J Surg. 2010 Jun;34(6):1214-21. doi: 10.1007/s00268-009-0375-x.
2
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.甲状腺微小乳头状癌的癌症复发:对231例患者进行12年随访的多因素分析
Minerva Endocrinol. 2013 Sep;38(3):269-79.
3
Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.339例甲状腺乳头状微小癌患者中意外发现及非意外发现病例的临床和病理特征
Head Neck. 2014 Apr;36(4):564-70. doi: 10.1002/hed.23333. Epub 2013 Jun 18.
4
Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.导致甲状腺乳头癌和微小乳头状癌预后差异的风险因素。
Am J Surg. 2013 Oct;206(4):586-93. doi: 10.1016/j.amjsurg.2013.02.008. Epub 2013 Jun 19.
5
Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.甲状腺微小乳头状癌患者淋巴结转移的预测因素:293 例回顾性分析。
Front Endocrinol (Lausanne). 2020 Aug 25;11:551. doi: 10.3389/fendo.2020.00551. eCollection 2020.
6
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
7
[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].可切除性甲状腺微小乳头状癌的临床病理特征
Zhonghua Zhong Liu Za Zhi. 2017 May 23;39(5):361-366. doi: 10.3760/cma.j.issn.0253-3766.2017.05.008.
8
Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌转移性淋巴结的危险因素
Cir Esp (Engl Ed). 2020 Apr;98(4):219-225. doi: 10.1016/j.ciresp.2019.10.003. Epub 2020 Jan 21.
9
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.甲状腺微小乳头状癌手术的临床病理特征、预后及其与BRAFV600E突变状态和血管生成因子表达的关系
PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.
10
Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.254例甲状腺微小乳头状癌患者的甲状腺切除术和淋巴结清扫范围:单机构经验
Ann Surg Oncol. 2009 Apr;16(4):920-8. doi: 10.1245/s10434-009-0332-9. Epub 2009 Feb 3.

引用本文的文献

1
Papillary Thyroid Microcarcinoma in Thyroid Surgical Practice: Incidental vs. Non-Incidental: A Ten-Year Comparative Study.甲状腺外科实践中的甲状腺微小乳头状癌:意外发现型与非意外发现型:一项十年对比研究
Cancers (Basel). 2025 Jun 18;17(12):2029. doi: 10.3390/cancers17122029.
2
Analysis of risk factors and construction of a predictive model for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma.单侧甲状腺乳头状癌患者对侧隐匿性癌的危险因素分析及预测模型构建
Front Endocrinol (Lausanne). 2025 Apr 24;16:1532840. doi: 10.3389/fendo.2025.1532840. eCollection 2025.
3
Prognostic Impact of Primary Tumor Size in Papillary Thyroid Carcinoma without Lymph Node Metastasis.

本文引用的文献

1
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?甲状腺乳头状癌和微小癌:有必要区分这两者吗?
Thyroid. 2009 May;19(5):473-7. doi: 10.1089/thy.2008.0185.
2
BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management.甲状腺微小乳头状癌中的BRAF突变:更好风险管理的前景。
Ann Surg Oncol. 2009 Apr;16(4):801-3. doi: 10.1245/s10434-008-0298-z. Epub 2009 Jan 22.
3
An update on papillary microcarcinoma.乳头状微癌的最新进展。
原发性肿瘤大小对无淋巴结转移的乳头状甲状腺癌的预后影响
Endocrinol Metab (Seoul). 2025 Jun;40(3):405-413. doi: 10.3803/EnM.2024.2199. Epub 2025 Feb 25.
4
Comparison of the value of ultrasound-guided fine needle aspiration biopsy and contrast-enhanced ultrasound in different sizes of thyroid nodules.超声引导下细针抽吸活检与超声造影在不同大小甲状腺结节中的价值比较。
Medicine (Baltimore). 2024 Sep 27;103(39):e39843. doi: 10.1097/MD.0000000000039843.
5
Papillary thyroid microcarcinoma with and without nodal metastasis: A comparative analysis.甲状腺微小乳头状癌伴与不伴淋巴结转移的比较分析。
Saudi Med J. 2024 Mar;45(3):267-272. doi: 10.15537/smj.2024.45.3.20230638.
6
The ultrasound-based radiomics-clinical machine learning model to predict papillary thyroid microcarcinoma in TI-RADS 3 nodules.基于超声的影像组学-临床机器学习模型用于预测TI-RADS 3类结节中的甲状腺微小乳头状癌。
Transl Cancer Res. 2024 Jan 31;13(1):278-289. doi: 10.21037/tcr-23-1375. Epub 2024 Jan 12.
7
Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?甲状腺微小乳头状癌的管理策略选择:主动监测还是立即手术?
J Cancer. 2024 Jan 1;15(4):1009-1020. doi: 10.7150/jca.91612. eCollection 2024.
8
Evaluation of Etiology, Clinical Manifestations, Diagnosis, Follow-up, Histopathology and Prognosis Factors in Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.甲状腺微小乳头状癌的病因、临床表现、诊断、随访、组织病理学及预后因素评估:一项系统评价与Meta分析
Iran J Pathol. 2023;18(4):380-391. doi: 10.30699/IJP.2023.2005196.3134. Epub 2023 Oct 15.
9
The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.单侧多灶性甲状腺乳头状癌中肿瘤总直径的价值:倾向评分匹配分析。
Front Endocrinol (Lausanne). 2023 Sep 6;14:1217613. doi: 10.3389/fendo.2023.1217613. eCollection 2023.
10
Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.意大利 2001-2018 年全甲状腺切除术后放射性碘治疗趋势。
Eur Thyroid J. 2023 Jul 12;12(4):e230051. doi: 10.1530/ETJ-23-0051.
Curr Opin Oncol. 2009 Jan;21(1):1-4. doi: 10.1097/CCO.0b013e32831a9a82.
4
Increasing incidence of thyroid cancer is due to increased pathologic detection.甲状腺癌发病率的上升是由于病理检测的增加。
Surgery. 2008 Dec;144(6):1038-43; discussion 1043. doi: 10.1016/j.surg.2008.08.023.
5
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.甲状腺微小乳头状癌:一项为期60年的900例病例研究。
Surgery. 2008 Dec;144(6):980-7; discussion 987-8. doi: 10.1016/j.surg.2008.08.035.
6
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study.甲状腺乳头状微小癌:一项描述性和荟萃分析研究。
Eur J Endocrinol. 2008 Dec;159(6):659-73. doi: 10.1530/EJE-07-0896. Epub 2008 Aug 19.
7
Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.甲状腺微小乳头状癌的中央区颈淋巴结转移:转移模式及转移的预测因素
Ann Surg Oncol. 2008 Sep;15(9):2482-6. doi: 10.1245/s10434-008-0044-6. Epub 2008 Jul 9.
8
Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion?所有甲状腺结节小于一厘米的患者都应该接受细针穿刺活检和术前颈部超声检查以确定肿瘤侵犯范围吗?
Thyroid. 2008 Jun;18(6):597-602. doi: 10.1089/thy.2008.0100.
9
Incidental and nonincidental papillary thyroid microcarcinoma.偶然发现的和非偶然发现的甲状腺乳头状微小癌。
Ann Surg Oncol. 2008 Aug;15(8):2287-92. doi: 10.1245/s10434-008-9958-2. Epub 2008 May 16.
10
Papillary microcarcinoma.乳头状微癌
World J Surg. 2008 May;32(5):747-53. doi: 10.1007/s00268-007-9453-0.